Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Furuya

Showing results (181-190 of 193) with videos related to

Pageof 20
Sort By:
Human Molecular Genetics|October 11, 2018
Homozygosity for a mutation affecting the catalytic domain of tyrosyl-tRNA synthetase (YARS) causes multisystem diseaseKatie B Williams, Karlla W Brigatti, Erik G Puffenberger, et al.
JHEP Reports : Innovation in Hepatology|June 26, 2026
Longitudinal GGT Trajectories Identify Prognostic Phenotypes in Paediatric Primary Sclerosing CholangitisDaniela Denier, Yiming Emmett Peng, Mansi Amin, et al.
The New England Journal of Medicine|September 10, 2015
A Phase 3 Trial of Sebelipase Alfa in Lysosomal Acid Lipase DeficiencyBarbara K Burton, Manisha Balwani, François Feillet, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 4, 2020
Colorectal Dysplasia and Cancer in Pediatric-Onset Ulcerative Colitis Associated With Primary Sclerosing CholangitisWael El-Matary, Stephen L Guthery, Achiya Z Amir, et al.
Pediatric Transplantation|June 16, 2025
The Society of Pediatric Liver Transplantation (SPLIT): 2023 Registry StatusAnna M Banc-Husu, Rachel Smith, Beau Kelly, et al.
Hepatology (Baltimore, Md.)|September 18, 2020
Oral Vancomycin, Ursodeoxycholic Acid, or No Therapy for Pediatric Primary Sclerosing Cholangitis: A Matched AnalysisMark R Deneau, Cara Mack, Douglas Mogul, et al.
Journal of Pediatric Gastroenterology and Nutrition|October 26, 2019
Assessing the Validity of Adult-derived Prognostic Models for Primary Sclerosing Cholangitis Outcomes in ChildrenMark R Deneau, Pamela L Valentino, Cara Mack, et al.
Hepatology Communications|November 10, 2018
Gamma Glutamyltransferase Reduction Is Associated With Favorable Outcomes in Pediatric Primary Sclerosing CholangitisMark R Deneau, Cara Mack, Reham Abdou, et al.
Hepatology (Baltimore, Md.)|May 19, 2021
Recurrence of Primary Sclerosing Cholangitis After Liver Transplant in Children: An International Observational StudyMercedes Martinez, Emily R Perito, Pamela Valentino, et al.
Alimentary Pharmacology & Therapeutics|March 11, 2024
Oral vancomycin is associated with improved inflammatory bowel disease clinical outcomes in primary sclerosing cholangitis-associated inflammatory bowel disease (PSC-IBD): A matched analysis from the Paediatric PSC ConsortiumAmanda Ricciuto, Kuan Liu, Wael El-Matary, et al.
Pageof 20

Showing results (181-190 of 193) with videos related to

Sort By:
Pageof 20
Human Molecular Genetics|October 11, 2018
Homozygosity for a mutation affecting the catalytic domain of tyrosyl-tRNA synthetase (YARS) causes multisystem diseaseKatie B Williams, Karlla W Brigatti, Erik G Puffenberger, et al.
JHEP Reports : Innovation in Hepatology|June 26, 2026
Longitudinal GGT Trajectories Identify Prognostic Phenotypes in Paediatric Primary Sclerosing CholangitisDaniela Denier, Yiming Emmett Peng, Mansi Amin, et al.
The New England Journal of Medicine|September 10, 2015
A Phase 3 Trial of Sebelipase Alfa in Lysosomal Acid Lipase DeficiencyBarbara K Burton, Manisha Balwani, François Feillet, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 4, 2020
Colorectal Dysplasia and Cancer in Pediatric-Onset Ulcerative Colitis Associated With Primary Sclerosing CholangitisWael El-Matary, Stephen L Guthery, Achiya Z Amir, et al.
Pediatric Transplantation|June 16, 2025
The Society of Pediatric Liver Transplantation (SPLIT): 2023 Registry StatusAnna M Banc-Husu, Rachel Smith, Beau Kelly, et al.
Hepatology (Baltimore, Md.)|September 18, 2020
Oral Vancomycin, Ursodeoxycholic Acid, or No Therapy for Pediatric Primary Sclerosing Cholangitis: A Matched AnalysisMark R Deneau, Cara Mack, Douglas Mogul, et al.
Journal of Pediatric Gastroenterology and Nutrition|October 26, 2019
Assessing the Validity of Adult-derived Prognostic Models for Primary Sclerosing Cholangitis Outcomes in ChildrenMark R Deneau, Pamela L Valentino, Cara Mack, et al.
Hepatology Communications|November 10, 2018
Gamma Glutamyltransferase Reduction Is Associated With Favorable Outcomes in Pediatric Primary Sclerosing CholangitisMark R Deneau, Cara Mack, Reham Abdou, et al.
Hepatology (Baltimore, Md.)|May 19, 2021
Recurrence of Primary Sclerosing Cholangitis After Liver Transplant in Children: An International Observational StudyMercedes Martinez, Emily R Perito, Pamela Valentino, et al.
Alimentary Pharmacology & Therapeutics|March 11, 2024
Oral vancomycin is associated with improved inflammatory bowel disease clinical outcomes in primary sclerosing cholangitis-associated inflammatory bowel disease (PSC-IBD): A matched analysis from the Paediatric PSC ConsortiumAmanda Ricciuto, Kuan Liu, Wael El-Matary, et al.
Pageof 20